UDP-glucuronosyltransferases (UGTs): From purification of Ah-receptorinducible UGT1A6 to coordinate regulation of subsets of CYPs, UGTs, and ABC transporters by nuclear receptors

Drug Metabolism Reviews

Volumn 42, Issue 1, 2010, Pages 6-13

  Bock, Karl W ^a   Bock Hennig, Barbara S ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Ah receptor; CAR; CYPs; PXR; UDP glucuronosyltransferases

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; ABC TRANSPORTER; AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; BETA NAPHTHOFLAVONE; BILIRUBIN; BILIVERDIN; CARBAZOLE DERIVATIVE; CELL NUCLEUS RECEPTOR; CYTOCHROME; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A6; INDIRUBIN; KAEMPFEROL; LEUKOTRIENE DERIVATIVE; LIPOXIN A; PHENOBARBITAL; QUERCETIN; RESVERATROL;

ENHANCER REGION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME PURIFICATION; ENZYME REGULATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; REVIEW; XENOBIOTIC METABOLISM;

EID: 74549214981     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602530903205492     Document Type: Review

References (73)

1. Abid, A., Bouchon, I., Siest, G., Sabolovic, N. (1995). Glucuronidation in the Caco-2 intestinal cell line: induction of UDP-glucuronosyltransferase 1*6. Biochem Pharmacol 50:557-561.
2. Benoit-Biancamano, M. O., Connelly, J., Villeneuve, L., Caron, P., Guillemette, C. (2009). Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Drug Metab Disp 37:322-329.
3. Bock, K. W. (1974). Oxidation of barbiturates and the glucuronidation of 1-naphthol in perfused rat liver and in microsomes. Naunyn-Schmiedeber's Arch Pharmacol 283:319-330.
4. Bock, K. W. (2003). Vertebrate UDP-glucuronosyltransferases: functional and evolutionary aspects. Biochem Pharmacol 66:691-696.
5. Bock, K. W., Bock-Hennig, B. S. (1987). Diferential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers. Biochem Pharmacol 36:4137-4143.
6. Bock, K. W., Köhle, C. (2006). Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72:393-404.
7. Bock, K. W., Köhle, C. (2009). Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 77:1458-1465.
8. Bock, K. W., White, I. (1974). UDP-glucuronyltransferase in perfused rat liver and in microsomes: infuence of phenobarbital and 3-methylcholanthrene. Eur J Biochem 46:451-459.
9. Bock, K. W., Eckle, T., Ouzzine, M., Fournel-Gigleux, S. (2000). Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical export pump, MRP2 (multidrug resistance protein 2), in Caco-2 cells. Biochem Pharmacol 59:467-470.
10. Bock, K. W., Forster, A., Gschaidmeier H., Brück, M, Münzel, P., Scharek, W., Fournel-Gigleux, S., et al. (1993). Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol 45:1809-1814.
11. Bock, K. W., Fröhling, W., Remmer, H., Rexer, B. (1973). Efects of phenobarbital and 3-methylcholanthrene on substrate specif-city of rat liver microsomal UDP-glucuronyltransferase. Biochim Biophys Acta 327:46-56.
12. Bock, K. W., Gschaidmeier, H., Seidel, A., Baird, B., Burchell, B. (1992). Mono-and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1). Mol Pharmacol 42:613-618.
13. Bock, K. W., Josting, D., Lilienblum, W., Pfeil, H. (1979). Purifcation of rat liver microsomal UDP-glucuronyltransferase. Separation of two enzyme forms inducible by 3-methylcholanthrene or phenobarbital. Eur J Biochem 98:19-26. (Pubitemid 9228899)
14. Bock, K. W., Lilienblum, W., Pfeil, H. (1982). Functional heterogeneity of UDP-glucuronosyltransferase activities in C57BL/6 and DBA/2 mice. Biochem Pharmacol 31:1273-1277.
15. Bock, K. W., Lilienblum, W., von Bahr, C. (1984). Studies of UDP-glucuroyltransferase activities in human liver microsomes. Drug Metab Disp 12:93-97. (Pubitemid 14189047)
16. Bock, K. W., Lipp, H. P., Bock-Hennig, B. S. (1990b). Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica 20:1101-1111.
17. Bock, K. W., Münzel, P. A., Röhrdanz, E., Schrenk, D., Eriksson, L. C. (1990a). Persistently increased expression of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas. Cancer Res 50:3569-3573.
18. Bock, K. W., Schirmer, G., Green, M. D., Tephly, T. R. (1988). Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat liver. Biochem Pharmacol 37:1439-1443.
19. Bock, K. W., Schrenk, D., Forster, A., Griese, E. U., Mörike, K., Brockmeier, D., et al. (1994). Te infuence of environmental and genetic factors on CYP2D6, CYP1A2, and UDP-glucuronosyltransferases in man using sparteine, cafeine, and paracetamol as probes. Pharmacogenetics 4:209-218.
20. Bock, K. W., Wiltfang, J., Blume, R., Ullrich, D., Bircher J. (1987). Paracetamol as a test drug to determine glucuronide formation in man: efects of inducers and of smoking. Eur J Clin Pharmacol 31:677-683.
21. Bock-Hennig, B. S., Köhle, C., Nill, K., Bock, K. W. (2002). Infuence of t-butylhydroquinone and β-naphthofavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/ TC-7 cell monolayers. Biochem Pharmacol 63:123-128.
22. Braeuning, A., Sanna, R., Huelsken, J., Schwarz, M. (2009). Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specifc knockout of Ctnnb1. Drug Metab Disp 37:1138-1145.
23. Brands, A., Münzel, P. A., Bock, K. W. (2000). In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem Pharmacol 59:1441-1444.
24. Chen, S., Beaton, D., Nguyen, N., Senekeo-Efenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specifc, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547-37557.
25. Chiaro, C. R., Patel, R. D., Marcus, C. B., Perdew, G. H. (2007). Evidence for an aryl hydrocarbon receptor-mediated cytochrome P450 autoregulatory pathway. Mol Pharmacol 72:1369-1379.
26. Court, M. H., Duan, S. X., von Moltke, L.L., Greenblatt, D. J., Patten, C. J., Miners, J. O., et al. (2001). Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identifca-tion of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J Pharmacol Exp Ter 299:998-1006.
27. Crespy, V., Morand, C., Manach, C., Besson, C., Demigne, C., Remesy, C. (1999). Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. Am J Physiol 277(Gastrointest Liver Physiol 40):G120-G126.
28. Dutton, G. J. (1975). Control of UDP-glucuronyltransferase activity. Biochem Pharmacol 24:1835-1841.
29. Emi, Y., Ikushiro, S., Iyanagi, T. (1996). Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J Biol Chem 271:3952-3958.
30. Estabrook, R. W. (1971). Cytochrome P-450: its function in the oxidative metabolism of drugs. Handbook Exp Pharmacol 28:264-284.
31. Falany, C., Tephly, T. R. (1983). Separation, purifcation, and characterization of three isoenzymes of UDP-glucuronyltransferase from rat liver microsomes. Arch Biochem Biophys 227:248-258.
32. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., et al. (1995). Immune system impairment and hepatic fbrosis in mice lacking the dioxin-binding Ah receptor. Science 268:722-726.
33. Gschaidmeier, H., Bock, K. W. (1994). Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalyzing mono-and diglucuronide formation of 3,6-dihydroxybenzo(a) pyrene and 3,6-dihydroxychrysene. Biochem Pharmacol 48:1545-1549.
34. Gschaidmeier, H., Seidel, A., Burchell, B., Bock, K. W. (1995). Formation of mono-and diglucuronides and other glycosides of benzo[a]pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Biochem Pharmacol 49:1601-1606.
35. Gu, Y. Z., Hogenesch, J. B., Bradfeld, C. A. (2000). Te PAS super-family: sensors of environmental and developmental signals. Ann Rev Pharmacol Toxicol 40:519-561.
36. Inscoe, J. K., Axelrod, J. (1960). Some factors afecting glucuronide formation in vitro. J Pharmacol Exp Ter 129:128-131.
37. Iyanagi, T., Haniu, M., Sogawa, K., Fujii-Kuriyama, Y., Watanabe, S., Shively, J. E., et al. (1986). Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyltransferase. J Biol Chem 261:15607-15614.
38. Jafe, S. J., Levy, D., Matsusawe, T., Baliah, T. (1966). Enhancement of glucuronide conjugating capacity in a hyperbilirubinemic infant due to apparent enzyme induction by phenobarbital. NEJM 275:461.
39. Kerkvliet, N. I. (2009). AHR-mediated immunomudulation: the role of altered gene transcription. Biochem Pharmacol 77:746-760.
40. King, C. D., Rios, G. R., Assouline, J. A., Tephly, T. R. (1999). Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identifcation of 5-hydroxytryptamine as a substrate. Arch Biochem Biophys 365:156-162.
41. Köhle, C., Bock, K. W. (2007). Coordinate regulation of phase I and II xenobiotic metabolism by the Ah receptor and Nrf2. Biochem Pharmacol 72:795-805.
42. Köhle, C., Bock, K. W. (2009). Coordinate regulation of human drug-metabolizing enzymes and conjugate transporters by the Ah receptor, pregnane X receptor, and constitutive androstane receptor. Biochem Pharmacol 73:1853-1862.
43. Köhle, C., Badary, O. A., Nill, K., Bock-Hennig, B. S., Bock, K. W. (2005). Serotonin glucuronidation by Ah receptor-and oxidative stress-inducible human UDP-glucuronosyltransferase (UGT) 1A6 in Caco-2 cells. Biochem Pharmacol 69:1397-1402.
44. Köhle, C., Schwarz, M., Bock, K. W. (2008). Promotion of hepato-carcinogenesis in humans and animal models. Arch Toxicol 82:623-631.
45. Krishnaswamy, S., Duan, S. X., von Moltke, L.L., Greenblatt, D. J., Court, M. H. (2003). Validation of serotonin (5-hydroxytryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Disp 31:133-139.
46. Krishnaswamy, S., Hao, Q., Al-Rohaimi, A., Hesse, L. M., von Moltke, L. L., Greenblatt, D. J., et al. (2005a). UDP glucurono-syltransferase (UGT) 1A6 pharmacogenetics: I. Identifcation of polymorphisms in the 5'-regulatory and exon 1 regions, association with human liver UGT1A6 gene expression, and glucuroni-dation. J Pharmacol Exp Ter 313:1331-1339.
47. Krishnaswamy, S., Hao, Q., Al-Rohaimi, A., Hesse, L. M., von Moltke, L.L., Greenblatt, D. J., et al. (2005b) UDP-glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UDP1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ter 313:1340-1346.
48. Lilienblum, W., Bock-Hennig, B. S., Bock, K. W. (1985). Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono-and diglucuronide. Mol Pharmacol 27:451-458.
49. Little, J. M., Kurkela, M., Sonka, J., Jäntti, S., Ketola, R., Bratton, S., et al. (2004). Glucuronidation of oxidized fatty acids and pros-taglandins B1 and E2 by human hepatic and recombinant UDP- glucuronosyltransferases. J Lipid Res 45:1694-1703.
50. Mackenzie, P. I. (1986). Rat liver UDP-glucuronosyltransferase: sequence and expression of a cDNA encoding a phenobarbital-inducible form. J Biol Chem 261:6119-6125.
51. Mackenzie, P. I., Bock, K. W., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genom 15:677-685.
52. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997). Te UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
53. Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., Kliewer, S. A. (2002). Nuclear pregnane X receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxifcation. Mol Pharmacol 62:638-646.
54. Maines, M. D. (2005). New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology 20:382-389.
55. Maron, D. M., Ames, B. N. (1983). Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173-215.
56. Münzel, P. A., Brück, M., Bock, K. W. (1994). Tissue-specifc constitutive and inducible expression of rat phenol UDP-glucuronyltransferase. Biochem Pharmacol 47:1445-1448.
57. Münzel, P. A., Lehmköster, T., Brück, M., Ritter, J. K., Bock, K. W. (1998). Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch Biochem Biophys 350:72-78.
58. Münzel, P. A., Schmohl, S., Buckler, F., Jaehrling, J., Raschko, F. T., Köhle, C., et al. (2003). Contribution of the Ah receptor to the phenolic antioxidant-mediated expression of human and rat UDP- glucuronosyltransferase UGT1A6 in Caco-2 and rat hepatoma 5L cells. Biochem Pharmacol 66:841-847.
59. Nebert, D. W., Dalton, T. P., Okey, A. B., Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279:23847-23850.
60. Nguyen, L-P., Bradfeld, C. A. (2008). Te search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol 21:102-116.
61. Orzechowski, A., Schrenk, D., Bock-Hennig, B. S., Bock, K. W. (1994). Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferases of the UGT1 gene complex. Carcinogenesis 15:1549-1553.
62. Owens, I. S. (1977). Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. J Biol Chem 252:2827-2833.
63. Patel, R. D., Hollingshead, B. D., Omiecinski, C. J., Perdew, G. H. (2007). Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver. Mol Pharmacol 46:209-218.
64. Phelan, D., Winter, G. M., Rogers, W. J., Lam, J. C., Denison, M. S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357:155-163.
65. Ritter, J. K., Kessler, F. K., Tompson, M. T., Grove, A. D., Auyeung, D. J., Fisher, R. A. (1999). Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental infuences. Hepatology 30:476-484.
66. Sedlak, T. W., Saleh, M., Higginson, D. S., Paul, B. D., Juluri, K. R., Snyder, S. H. (2009). Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc Natl Acad Sci U S A 106:5171-5176.
67. Sinal, C. P., Bend, J. P. (1997). Aryl hydrocarbon receptor-dependent induction of CYP1a1 by bilirubin in mouse hepatoma Hepa 1c1c7 cells. Mol Pharmacol 52:590-599.
68. Soars, M. G., Petullo, D. M., Eckstein, J. A., Kasper, S. C., Wrighton, S. A. (2004). An assessment of UGP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab Disp 32:140-148.
69. Stramentinoli, G., Gazzaniga, A., Della Bella, D., Remmer, H. (1974). Increase of chloramphenicol glucuronidation in rats treated with phenobarbital. Biochem Pharmacol 23:1181-1186.
70. Sugatani, J., Sueoshi, T., Negishi, M., Miva, M. (2005). Regulation of the human UGT1A1 gene by nuclear receptors constitutive active/androstane receptor, pregnane X receptor, and glucocor-ticoid receptor. Meth Enzymol 400:92-104. (Pubitemid 43052417)
71. Toriyabe, T., Nagata, K., Takada T., Aratsu, Y., Matsubara, T., Yoshinari, K., et al. (2009). Unveiling a new essential cis-element for transactivation of the CYP3A4 gene by xenobiotics. Mol Pharmacol 75:677-684.
72. Walle, U. K., Galijatovic, A., Walle, T. (1999). Transport of the favo-noid chrysin and its conjugated metabolites by the human intestinal cell line, Caco-2. Biochem Pharmacol 58:431-438.
73. Yueh, M. F., Huang, Y. H., Hiller, A., Chen, S., Nguyen, N., Tukey, R. H. (2003). Involvement of the xenobiotic element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 276:15001-15006